Welcome Guest
Sign In
Register
Products
Popular Categories
Antibody Search
ELISA Kit Search
Biomolecules
Flow Cytometers
Thermal Cyclers
Microscopes
Transfection Reagents
Featured Products
New Products
Research Areas
ELISA
Western Blot
3D Cell Culture
Digital PCR
Quantitative PCR
Cell and Gene Therapy
In Vivo Models
Resources
eBooks
Bench Tips
Tech Insights
Editorial Articles
News
Product Reviews
Future Lab
White Papers
Infographics
Events
Promotions
Multimedia
Biocompare Webinars
Technologies Transforming Precision Medicine
Immunotherapy
Reproducibility
Transformative Technologies
Podcasts
Bench Tip Videos
All Videos and Webinars
Life Science Webinars
Write a Review
Antibodies
Kits/Reagents
Equipment
Services
Register
Sign In
Biocompare
Products
RNAi Technology
RNAi
FXYD3 siRNA (h)
Supplier Images
Published Figures
FXYD3 siRNA (h)
FXYD3 siRNA (h) from Santa Cruz Biotechnology, Inc.
Be the first to write a review!
Citations:
(2)
Figures:
(6)
Supplier Page
Supplier Page from
Santa Cruz Biotechnology, Inc. for
FXYD3 siRNA (h)
Description
FXYD3 siRNA (h)
Product Specs
Company Info
Citations
Reviews
Product Specs
Item
FXYD3 siRNA (h)
Company
Santa Cruz Biotechnology, Inc.
Price
$293.00
Supplier Page
View Company Product Page
Catalog Number
sc-60665
Gene Name
FXYD domain containing ion transport regulator 3
Quantity
10 µM
Species
human
NCBI Full Gene Name
FXYD domain containing ion transport regulator 3
NCBI Gene Aliases
MAT8, PLML
Type
siRNA/dsRNA
Add to Compare List
Santa Cruz Biotechnology, Inc.
10410 Finnell Street
Dallas
,
Texas
75220
United States
Phone
: 1-800-457-3801
831-457-3801
Company Profile
Website:
http://www.scbt.com/
Citations (2)
(1)
Displacement of Native FXYD Protein From Na(+)/K(+)-ATPase With Novel FXYD Peptide Derivatives: Effects on Doxorubicin Cytotoxicity
Frontiers in oncology
January 1, 2022
Liu CC, Kim YJ, Teh R, Garcia A, Hamilton EJ, Cornelius F, Baxter RC, Rasmussen HH.
(consisting of pools of three to five target-specific 19–25-nt siRNAs designed to knock down
gene expression
,
sc-60665
) and the non-silencing control (
control siRNA-A
,
sc-37007
) were purchased from
Santa Cruz Biotechnology
(2)
Silencing overexpression of FXYD3 protein in breast cancer cells amplifies effects of doxorubicin and γ-radiation on Na(+)/K(+)-ATPase and cell survival
Breast cancer research and treatment
January 1, 2016
Liu CC, Teh R, Mozar CA, Baxter RC, Rasmussen HH.
<<
<
>
>>
Reviews
Be the First to Write a Review!
FXYD3 siRNA (h) from Santa Cruz Biotechnology, Inc.
Supplier Page
View Company Product Page
$293.00
Product Specs
Company Info
Citations
Reviews
Back To Top